Literature DB >> 1904222

The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture.

K Uçar1.   

Abstract

B16-C3 murine melanoma, A375P human melanotic melanoma, and C32 human amelanotic melanoma cells were incubated in the presence of (0-4 mM) H2-antagonists, ranitidine and cimetidine. Cell proliferation, tyrosinase activity and melanin content were monitored. H2-antagonists stimulated tyrosinase activity and melanin accumulation in B16-C3 cells in a dose- and time-dependent manner. Stimulation of enzyme activity and pigment production was accompanied by inhibition of cellular proliferation in B16-C3 cells. The inhibitory concentration of cimetidine was approximately 2-fold higher than that of ranitidine. H2-antagonists failed to stimulate melanogenesis in A375P or C32 cells, but inhibited cellular proliferation in both cell lines. These results are the first demonstration of H2-antagonist induced phenotypic changes in malignant melanoma cells in vitro, and represent a novel mechanism for the previously described in vivo antitumor effects of these agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904222     DOI: 10.1016/0006-291x(91)92018-f

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Histamine as an autocrine growth factor in experimental mammary carcinomas.

Authors:  G P Cricco; C A Davio; G Martin; N Engel; C P Fitzsimons; R M Bergoc; E S Rivera
Journal:  Agents Actions       Date:  1994-11

3.  Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

Authors:  L T Van der Ven; S C Van Buul-Offers; T Gloudemans; P J Roholl; J S Sussenbach; W Den Otter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.